AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
NO EVIDENCE FOR MUC 1-INDUCED APOPTOSIS
Authors: BOUSSIOTIS VA FREEMAN GJ GRIBBEN JG HAYES DF NADLER LM
Citation: Va. Boussiotis et al., NO EVIDENCE FOR MUC 1-INDUCED APOPTOSIS, Nature medicine, 4(10), 1998, pp. 1093-1093
DETERMINATION OF CLINICAL UTILITY OF TUMOR-MARKERS - A TUMOR-MARKER UTILITY GRADING SYSTEM
Authors: HAYES DF
Citation: Df. Hayes, DETERMINATION OF CLINICAL UTILITY OF TUMOR-MARKERS - A TUMOR-MARKER UTILITY GRADING SYSTEM, European journal of cancer, 34, 1998, pp. 10-10
DO PROGNOSTIC MARKER STUDIES ON CORE NEEDLE-BIOPSY SPECIMENS OF BREAST-CARCINOMA ACCURATELY REFLECT THE MARKER STATUS OF THE TUMOR
Authors: JACOBS TW SIZIOPIKOU KP PRIOLEAU JE RAZA S BAUM JK HAYES DF SCHNITT SJ
Citation: Tw. Jacobs et al., DO PROGNOSTIC MARKER STUDIES ON CORE NEEDLE-BIOPSY SPECIMENS OF BREAST-CARCINOMA ACCURATELY REFLECT THE MARKER STATUS OF THE TUMOR, Modern pathology, 11(3), 1998, pp. 259-264
PHASE-II STUDY OF RECEPTOR-ENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185(HER2 NEU) MONOCLONAL-ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST-CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT/
Authors: PEGRAM MD LIPTON A HAYES DF WEBER BL BASELGA JM TRIPATHY D BALY D BAUGHMAN SA TWADDELL T GLASPY JA SLAMON DJ
Citation: Md. Pegram et al., PHASE-II STUDY OF RECEPTOR-ENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185(HER2 NEU) MONOCLONAL-ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST-CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT/, Journal of clinical oncology, 16(8), 1998, pp. 2659-2671
1997 UPDATE OF RECOMMENDATIONS FOR THE USE OF TUMOR-MARKERS IN BREASTAND COLORECTAL-CANCER
Authors: BAST RC DESCH CE HAYES DF KEMENY NE RAVDIN P SOMERFIELD MR SMITH TJ
Citation: Rc. Bast et al., 1997 UPDATE OF RECOMMENDATIONS FOR THE USE OF TUMOR-MARKERS IN BREASTAND COLORECTAL-CANCER, Journal of clinical oncology, 16(2), 1998, pp. 793-795
CARDIAC EFFECTS OF ADJUVANT DOXORUBICIN AND RADIATION-THERAPY IN BREAST-CANCER PATIENTS
Authors: SHAPIRO CL HARDENBERGH PH GELMAN R BLANKS D HAUPTMAN P RECHT A HAYES DF HARRIS J HENDERSON IC
Citation: Cl. Shapiro et al., CARDIAC EFFECTS OF ADJUVANT DOXORUBICIN AND RADIATION-THERAPY IN BREAST-CANCER PATIENTS, Journal of clinical oncology, 16(11), 1998, pp. 3493-3501
ENHANCING WATER-QUALITY IN HYDROPOWER SYSTEM OPERATIONS
Authors: HAYES DF LABADIE JW SANDERS TG BROWN JK
Citation: Df. Hayes et al., ENHANCING WATER-QUALITY IN HYDROPOWER SYSTEM OPERATIONS, Water resources research, 34(3), 1998, pp. 471-483
DUCTAL CARCINOMA IN-SITU OF THE BREAST - A NEW MODEL
Authors: HAYES DF
Citation: Df. Hayes, DUCTAL CARCINOMA IN-SITU OF THE BREAST - A NEW MODEL, Journal of the National Cancer Institute, 89(14), 1997, pp. 991-993
PREDICTION OF RESPONSE TO ANTIESTROGEN THERAPY IN ADVANCED BREAST-CANCER PATIENTS BY PRETREATMENT CIRCULATING LEVELS OF EXTRACELLULAR DOMAIN OF THE HER-2 C-NEU PROTEIN/
Authors: YAMAUCHI H ONEILL A GELMAN R CARNEY W TENNEY DY HOSCH S HAYES DF
Citation: H. Yamauchi et al., PREDICTION OF RESPONSE TO ANTIESTROGEN THERAPY IN ADVANCED BREAST-CANCER PATIENTS BY PRETREATMENT CIRCULATING LEVELS OF EXTRACELLULAR DOMAIN OF THE HER-2 C-NEU PROTEIN/, Journal of clinical oncology, 15(7), 1997, pp. 2518-2525
DO PROGNOSTIC MARKER STUDIES ON BREAST CORE NEEDLE-BIOPSY SPECIMENS ACCURATELY REFLECT THE MARKER STATUS OF THE TUMOR
Authors: JACOBS TW SIZIOPIKOU KP PRIOLEAU JE RAZA S BAUM JK HAYES DF SCHNITT SJ
Citation: Tw. Jacobs et al., DO PROGNOSTIC MARKER STUDIES ON BREAST CORE NEEDLE-BIOPSY SPECIMENS ACCURATELY REFLECT THE MARKER STATUS OF THE TUMOR, Laboratory investigation, 76(1), 1997, pp. 97-97
TUMOR-MARKER UTILITY GRADING SYSTEM - A FRAMEWORK TO EVALUATE CLINICAL UTILITY OF TUMOR-MARKERS
Authors: HAYES DF BAST RC DESCH CE FRITSCHE H KEMENY NE JESSUP JM LOCKER GY MACDONALD JS MENNEL RG NORTON L RAVDIN P TAUBE S WINN RJ
Citation: Df. Hayes et al., TUMOR-MARKER UTILITY GRADING SYSTEM - A FRAMEWORK TO EVALUATE CLINICAL UTILITY OF TUMOR-MARKERS, Journal of the National Cancer Institute, 88(20), 1996, pp. 1456-1466
BREAST CANCER-ASSOCIATED ANTIGEN, DF3 MUC1, INDUCES APOPTOSIS OF ACTIVATED HUMAN T-CELLS/
Authors: GIMMI CD MORRISON BW MAINPRICE BA GRIBBEN JG BOUSSIOTIS VA FREEMAN GJ PARK SYL WATANABE M GONG JL HAYES DF KUFE DW NADLER LM
Citation: Cd. Gimmi et al., BREAST CANCER-ASSOCIATED ANTIGEN, DF3 MUC1, INDUCES APOPTOSIS OF ACTIVATED HUMAN T-CELLS/, Nature medicine, 2(12), 1996, pp. 1367-1370
SHOULD WE TREAT HER, TOO
Authors: HAYES DF
Citation: Df. Hayes, SHOULD WE TREAT HER, TOO, Journal of clinical oncology, 14(3), 1996, pp. 697-699
CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST AND COLORECTAL-CANCER
Authors: BAST RC BATES S BREDT AB DESCH CE FRITSCHE H FUES L HAYES DF KEMENY NE KRAGEN M JESSUP J LOCKER GY MACDONALD JS MENNEL RG NORTON L RAVDIN P SMITH TJ TAUBE S WINN RJ
Citation: Rc. Bast et al., CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST AND COLORECTAL-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2843-2877
THE SEQUENCING OF CHEMOTHERAPY AND RADIATION-THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY-STAGE BREAST-CANCER
Authors: RECHT A COME SE HENDERSON IC GELMAN RS SILVER B HAYES DF SHULMAN LN HARRIS JR
Citation: A. Recht et al., THE SEQUENCING OF CHEMOTHERAPY AND RADIATION-THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY-STAGE BREAST-CANCER, The New England journal of medicine, 334(21), 1996, pp. 1356-1361
RECOMBINANT HUMAN STEM-CELL FACTOR (KIT-LIGAND) PROMOTES HUMAN MAST-CELL AND MELANOCYTE HYPERPLASIA AND FUNCTIONAL ACTIVATION IN-VIVO
Authors: COSTA JJ DEMETRI GD HARRIST TJ DVORAK AM HAYES DF MERICA EA MENCHACA DM GRINGERI AJ SCHWARTZ LB GALLI SJ
Citation: Jj. Costa et al., RECOMBINANT HUMAN STEM-CELL FACTOR (KIT-LIGAND) PROMOTES HUMAN MAST-CELL AND MELANOCYTE HYPERPLASIA AND FUNCTIONAL ACTIVATION IN-VIVO, The Journal of experimental medicine, 183(6), 1996, pp. 2681-2686
DOSE-ESCALATION OF N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE COMBINED WITH PENTOXIFYLLINE FOR ADVANCED BREAST-CANCER
Authors: SHAPIRO CL DEZUBE BJ TRETYAKOV O WRIGHT J CAP B HENDERSON IC HAYES DF
Citation: Cl. Shapiro et al., DOSE-ESCALATION OF N,N',N''-TRIETHYLENETHIOPHOSPHORAMIDE COMBINED WITH PENTOXIFYLLINE FOR ADVANCED BREAST-CANCER, Clinical cancer research, 1(8), 1995, pp. 791-796
DOXORUBICIN FOR INFLAMMATORY BREAST-CANCER - A RED HUMOR FOR A RED TUMOR
Authors: LEGLER CM HAYES DF
Citation: Cm. Legler et Df. Hayes, DOXORUBICIN FOR INFLAMMATORY BREAST-CANCER - A RED HUMOR FOR A RED TUMOR, Annals of surgical oncology, 2(4), 1995, pp. 283-285
WORSENING BONE-SCAN IN THE EVALUATION OF ANTITUMOR RESPONSE DURING HORMONAL-THERAPY OF BREAST-CANCER
Authors: VOGEL CL SCHOENFELDER J SHEMANO I HAYES DF GAMS RA
Citation: Cl. Vogel et al., WORSENING BONE-SCAN IN THE EVALUATION OF ANTITUMOR RESPONSE DURING HORMONAL-THERAPY OF BREAST-CANCER, Journal of clinical oncology, 13(5), 1995, pp. 1123-1128
RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HAYES DF VANZYL JA HACKING A GOEDHALS L BEZWODA WR MAILLIARD JA JONES SE VOGEL CL BERRIS RF SHEMANO I SCHOENFELDER J
Citation: Df. Hayes et al., RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2556-2566
TREATMENT OF METASTATIC BREAST-CANCER - PRESENT AND FUTURE-PROSPECTS
Authors: HAYES DF HENDERSON IC SHAPIRO CL
Citation: Df. Hayes et al., TREATMENT OF METASTATIC BREAST-CANCER - PRESENT AND FUTURE-PROSPECTS, Seminars in oncology, 22(2), 1995, pp. 5-21
RECOMBINANT HUMAN STEM-CELL FACTOR (SCF) (C-KIT LIGAND) PROMOTES MELANOCYTE HYPERPLASIA AND ACTIVATION IN-VIVO
Authors: HARRIST TJ COSTA JJ DEMETRI GD DVORAK AM HAYES DF MERICA EA MENCHACA D GRINGERI AJ GALLI SJ
Citation: Tj. Harrist et al., RECOMBINANT HUMAN STEM-CELL FACTOR (SCF) (C-KIT LIGAND) PROMOTES MELANOCYTE HYPERPLASIA AND ACTIVATION IN-VIVO, Laboratory investigation, 72(1), 1995, pp. 48-48
ELEVATED LEVELS OF AN ANGIOGENIC PEPTIDE, BASIC FIBROBLAST GROWTH-FACTOR, IN THE URINE OF PATIENTS WITH A WIDE SPECTRUM OF CANCERS
Authors: NGUYEN M WATANABE H BUDSON AE RICHIE JP HAYES DF FOLKMAN J
Citation: M. Nguyen et al., ELEVATED LEVELS OF AN ANGIOGENIC PEPTIDE, BASIC FIBROBLAST GROWTH-FACTOR, IN THE URINE OF PATIENTS WITH A WIDE SPECTRUM OF CANCERS, Journal of the National Cancer Institute, 86(5), 1994, pp. 356-361
TUMOR-MARKERS FOR BREAST-CANCER - CURRENT UTILITIES AND FUTURE-PROSPECTS
Authors: HAYES DF
Citation: Df. Hayes, TUMOR-MARKERS FOR BREAST-CANCER - CURRENT UTILITIES AND FUTURE-PROSPECTS, Hematology/oncology clinics of North America, 8(3), 1994, pp. 485-506
TUMOR-MARKERS IN ADULT SOLID MALIGNANCIES - PREFACE
Authors: HAYES DF
Citation: Df. Hayes, TUMOR-MARKERS IN ADULT SOLID MALIGNANCIES - PREFACE, Hematology/oncology clinics of North America, 8(3), 1994, pp. 180000009-180000010
Risultati: 1-25 | 26-34